(CIDRAP News) – Some professional groups and scientists think it's a good idea to classify highly pathogenic avian (HPAI) H5N1 influenza viruses as "select agents" requiring special research precautions, while others say the step is unnecessary and would impede research, according to comments they have filed with the US Department of Health and Human Services (HHS).
(CIDRAP News) – US influenza policy experts who gathered in Washington, DC, today called for better vaccines and other steps for improving pandemic and seasonal flu preparedness, themes echoed in an action plan released by the Infectious Diseases Society of America (IDSA).
(CIDRAP News) – More parents obtain medical vaccination exemptions for their kindergarten children in states where they are easier to get, which potentially reduces herd immunity and poses a threat to children who have real medical contraindications to vaccination, according to a study published yesterday in the Journal of Infectious Diseases.
(CIDRAP News) – Infectious-disease specialty groups are teaming up to call for increased use of antimicrobial stewardship programs, saying such efforts can help preserve the effectiveness of anti-infective drugs while reducing medical costs.
(CIDRAP News) – As part of its effort to shore up the waning supply of effective antimicrobials, the Infectious Diseases Society of America (IDSA) has proposed a streamlined approval pathway for antibiotics intended for special classes of patients who lack other treatment options.
Editors Note: This article covers research conducted in part by CIDRAP researchers. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.
See also: Strict meta-analysis raises questions about flu vaccine efficacy
(CIDRAP News) Warning that medical procedures such as surgery and chemotherapy will become impossible if current trends continue, the Infectious Diseases Society of America (IDSA) today called for a many-pronged campaign to counter the ever-growing threat of antimicrobial resistance.
(CIDRAP News) Although antiviral drugs were used to treat many seriously sick people during the H1N1 influenza pandemic, experts at a conference today said they could have been used more widely and that some opportunities to learn from their use were missed.